Additionally, our results showed a notable increase in effector-like CD8+ T cells in the spleen and decrease of stem-like CD8+ T cells in the tumor, which indicates HIF-PH inhibitors could promote CD8+ T cell differentiation. The gene discussed is CD8A; the disease is neoplasm.